Crystal structures of human glyoxalase I and its complex with TLSC702 reveal inhibitor binding mode and substrate preference

FEBS Lett. 2022 Jun;596(11):1458-1467. doi: 10.1002/1873-3468.14344. Epub 2022 Apr 8.

Abstract

Human glyoxalase I (hGLO I) is an enzyme for detoxification of methylglyoxal (MG) and has been considered an attractive target for the development of new anticancer drugs. In our previous report, the GLO I inhibitor TLSC702 induced apoptosis in tumor cells. Here, we determined the crystal structures of hGLO I and its complex with TLSC702. In the complex, the carboxyl O atom of TLSC702 is coordinated to Zn2+ , and TLSC702 mainly shows van der Waals interaction with hydrophobic residues. In the inhibitor-unbound structure, glycerol, which has similar functional groups to MG, was bound to Zn2+ , indicating that GLO I can easily bind to MG. This study provides a structural basis to develop better anticancer drugs.

Keywords: TLSC702; crystal packing; crystal structure; glycerol; glyoxalase I; methylglyoxal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Butyrates
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Lactoylglutathione Lyase* / chemistry
  • Lactoylglutathione Lyase* / metabolism
  • Thiazoles

Substances

  • 3-(1,3-benzothiazol-2-yl)-4-(4-methoxyphenyl)but-3-enoic acid
  • Antineoplastic Agents
  • Butyrates
  • Enzyme Inhibitors
  • Thiazoles
  • Lactoylglutathione Lyase